NCT06528119

Brief Summary

Physiological indicators such as blood pressure, heart rate, respiratory rate, and consciousness status of COVID-19 patients are used to apply the START (simple triage and rapid treatment, START), Modified Early Warning Score (MEWS), and quick Sequential Organ Failure Assessment (qSOFA) as tools for assessing clinical symptom tracking, deterioration, and subsequent improvement in COVID-19 patients. In response to the need for scarce manpower when a large number of emergency patients appear, a simple and easy-to-operate assessment method is adopted for mild patients, and artificial intelligence technology can be further used to assist in the assessment for early response and medication.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 30, 2020

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 20, 2024

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

July 29, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 30, 2024

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

1.6 years

First QC Date

July 29, 2024

Last Update Submit

July 30, 2024

Conditions

Keywords

blood pressureheart raterespiratory rateconsciousness statusquick Sequential Organ Failure Assessment (qSOFA)

Outcome Measures

Primary Outcomes (1)

  • COVID 19 pandemic

    Assessing clinical symptom tracking, deterioration, and subsequent improvement in COVID-19 patients.

    March 2020 and September 2022

Interventions

Physiological indicators such as blood pressure, heart rate, respiratory rate, and consciousness status of COVID-19 patients are used to apply the START, MEWS, and qSOFA in COVID-19 patients.(COVID 19 病患).

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

COVID 19 patients were treated in the hospital between March 2020 and Sep.2022

You may qualify if:

  • a group of hospitalized COVID 19 patients were treated in the hospital between March 2020 and Sep.2022

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Martin De Porres Hospital

Tainan, 60069, Taiwan

Location

MeSH Terms

Conditions

COVID-19

Interventions

Pandemic Preparedness

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Disaster PlanningDisastersEnvironmentEnvironment and Public HealthCommunicable Disease ControlPublic Health PracticePublic Health

Study Officials

  • Chia-Hsi Chen, MD

    St. Martin De Porres Hospital,emergency medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician of Emergency Medicine

Study Record Dates

First Submitted

July 29, 2024

First Posted

July 30, 2024

Study Start

September 30, 2020

Primary Completion

May 1, 2022

Study Completion

July 20, 2024

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations